Effect of mesenchymal stem cells and a novel curcumin derivative on notch1 signaling in hepatoma cell line

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Abdel Aziz, Mohamed Talaat ^a   Khaled, Hussien Mostafa ^b   El Hindawi, Ali ^a   Roshdy, Nagwa Kamal ^a   Rashed, Laila A ^a   Sabry, Dina ^a   Hassouna, Amira A ^a   Taha, Fatma ^a   Ali, Walaa Ibrahim ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLIN D1; NCD; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; NOTCH1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CENTRIFUGATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; CELL STRAIN HEPG2; DRUG EFFECT;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CURCUMIN; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MESENCHYMAL STROMAL CELLS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884246143     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/129629     Document Type: Article

References (53)

1. Jain S., Singhal S., Lee P., Xu R., Molecular genetics of hepatocellular neoplasia. American Journal of Translational Research 2010 2 1 105 118 2-s2.0-77953464861
2. Ibrahim A. S., Seifeldin I. A., Ismail K., Hablas A., Hussein H., Elhamzawy H., Cancer in Egypt, Gharbiah. Triennial Report of 2000-2002, Gharbiah Population-Based Cancer Registry 2007 Cairo, Egypt Middle East Cancer Consortium
3. Freedman L. S., Edwards B. K., Ries L. A. G., Young J. L., Cancer incidence in four member countries of the middle east cancer consortium (MECC) Compared with US SEER. 2006 NIH Pub. no. 06-5873 Bethesda, Md, USA National Cancer Institute
4. Yu M. C., Yuan J.-M., Lu S. C., Alcohol, cofactors and the genetics of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008 23 1 S92 S97 2-s2.0-40749113642 10.1111/j.1440-1746.2007.05293.x
5. Marra M., Sordelli I. M., Lombardi A., Lamberti M., Tarantino L., Giudice A., Stiuso P., Abbruzzese A., Sperlongano R., Accardo M., Agresti M., Caraglia M., Sperlongano P., Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. Journal of Translational Medicine 2011 9 1, article 171 2-s2.0-80053608796 10.1186/1479-5876-9-171
6. Yin L., Velazquez O. C., Liu Z.-J., Notch signaling: emerging molecular targets for cancer therapy. Biochemical Pharmacology 2010 80 5 690 701 2-s2.0-77954215506 10.1016/j.bcp.2010.03.026
7. Wang Z., Zhang Y., Li Y., Banerjee S., Liao J., Sarkar F. H., Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics 2006 5 3 483 493 2-s2.0-33645473185 10.1158/1535-7163.MCT-05-0299
8. Collins B. J., Kleeberger W., Ball D. W., Notch in lung development and lung cancer. Seminars in Cancer Biology 2004 14 5 357 364 2-s2.0-3342979755 10.1016/j.semcancer.2004.04.015
9. Ning L., Wentworth L., Chen H., Weber S. M., Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. American Journal of Translational Research 2009 1 4 358 366 2-s2.0-77953457718
10. Salamon A., Toldy E., Adult bone marrow derived mesenchymal stem cells as stem cells for tissue repair. Clinical and Experimental Medical Journal 2009 3 3 369 379 10.1556/CEMED.3.2009.28666
11. Maestroni G. J. M., Hertens E., Galli P., Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cellular and Molecular Life Sciences 1999 55 4 663 667 2-s2.0-0032952113 10.1007/s000180050322
12. Nakamura K., Ito Y., Kawano Y., Kurozumi K., Kobune M., Tsuda H., Bizen A., Honmou O., Niitsu Y., Hamada H., Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Therapy 2004 11 14 1155 1164 2-s2.0-4243125420 10.1038/sj.gt.3302276
13. Pisati F., Belicchi M., Acerbi F., Marchesi C., Giussani C., Gavina M., Javerzat S., Hagedorn M., Carrabba G., Lucini V., Gaini S. M., Bresolin N., Bello L., Bikfalvi A., Torrente Y., Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models. Cancer Research 2007 67 7 3054 3063 2-s2.0-34248206277 10.1158/0008-5472.CAN-06-1384
14. Liao S., Xia J., Chen Z., Zhang S., Ahmad A., Miele L., Sarkar F. H., Wang Z., Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of notch-1 and NF- B signaling pathways. Journal of Cellular Biochemistry 2011 112 4 1055 1065 2-s2.0-79952554406 10.1002/jcb.23019
15. Subramaniam D., Ponnurangam S., Ramamoorthy P., Standing D., Battafarano R. J., Anant S., Sharma P., Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 2012 7 2 2-s2.0-84857150040 10.1371/journal.pone.0030590 e30590
16. Rezq A., Abdel Aziz M. T., Kumosani T. A., Long acting conserved natural functional groups curcumin. EP 2365956 A2, 2011
17. Johnstone B., Hering T. M., Caplan A. I., Goldberg V. M., Yoo J. U., In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research 1998 238 1 265 272 2-s2.0-0031817577 10.1006/excr.1997.3858
18. Kadiyala S., Young R. G., Thiede M. A., Bruder S. P., Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplantation 1997 6 2 125 134 2-s2.0-0030907440 10.1016/S0963-6897(96)00279-5
19. Jaiswal N., Haynesworth S., Caplan A., Bruder S. P., Osteogenic differentiation of purified, culture- expanded human mesenchymal stem cells in vitro. Journal of Cellular Biochemistry 1997 64 295 312
20. Hou L., Cao H., Wang D., Wei G., Bai C., Zhang Y., Pei X., Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro. International Journal of Hematology 2003 78 3 256 261 2-s2.0-0142057516
21. Yamazoe K., Mishima H., Torigoe K., Iijima H., Watanabe K., Sakai H., Kudo T., Effects of atelocollagen gel containing bone marrow-derived stromal cells on repair of osteochondral defect in a dog. Journal of Veterinary Medical Science 2007 69 8 835 839 2-s2.0-34548459022 10.1292/jvms.69.835
22. Villanueva A., Newell P., Chiang D. Y., Friedman S. L., Llovet J. M., Genomics and signaling pathways in hepatocellular carcinoma. Seminars in Liver Disease 2007 27 1 55 76 2-s2.0-33847069207 10.1055/s-2006-960171
23. Llovet J. M., Di Bisceglie A. M., Bruix J., Kramer B. S., Lencioni R., Zhu A. X., Sherman M., Schwartz M., Lotze M., Talwalkar J., Gores G. J., Design and endpoints of clinical trials in hepatocellular carcinoma. Journal of the National Cancer Institute 2008 100 10 698 711 2-s2.0-44449085884 10.1093/jnci/djn134
24. Androutsellis-Theotokis A., Leker R. R., Soldner F., Hoeppner D. J., Ravin R., Poser S. W., Rueger M. A., Bae S.-K., Kittappa R., McKay R. D. G., Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006 442 7104 823 826 2-s2.0-33747513134 10.1038/nature04940
25. Miele L., Miao H., Nickoloff B. J., NOTCH signaling as a novel cancer therapeutic target. Current Cancer Drug Targets 2006 6 4 313 323 2-s2.0-33745509199 10.2174/156800906777441771
26. MacKenzie F., Duriez P., Wong F., Noseda M., Karsan A., Notch4 Inhibits endothelial apoptosis via RBP-J -dependent and -independent Pathways. Journal of Biological Chemistry 2004 279 12 11657 11663 2-s2.0-1642523576 10.1074/jbc.M312102200
27. Nair P., Somasundaram K., Krishna S., Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. Journal of Virology 2003 77 12 7106 7112 2-s2.0-0037941645 10.1128/JVI.77.12.7106-7112.2003
28. Oswald F., Liptay S., Adler G., Schmid R. M., NF- B2 is a putative target gene of activated Notch-1 via RBP-J Molecular and Cellular Biology 1998 18 4 2077 2088 2-s2.0-0031594575
29. Nickoloff B. J., Qin J.-Z., Chaturvedi V., Denning M. F., Bonish B., Miele L., Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF- B and PPAR γ Cell Death and Differentiation 2002 9 8 842 855 2-s2.0-0036024023 10.1038/sj.cdd.4401036
30. Bash J., Zong W.-X., Banga S., Rivera A., Ballard D. W., Ron Y., Gélinas C., Rel/NF- B can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO Journal 1999 18 10 2803 2811 2-s2.0-0033577768 10.1093/emboj/18.10.2803
31. Ronchini C., Capobianco A. J., Induction of cyclin D1 transcription and CDK2 activity by Notchic: implication for cell cycle disruption in transformation by Notchic. Molecular and Cellular Biology 2001 21 17 5925 5934 2-s2.0-0034902568 10.1128/MCB.21.17.5925-5934.2001
32. Murata K., Hattori M., Hirai N., Shinozuka Y., Hirata H., Kageyama R., Sakai T., Minato N., Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1. Molecular and Cellular Biology 2005 25 10 4262 4271 2-s2.0-18144386919 10.1128/MCB.25.10.4262-4271.2005
33. Levicar N., Dimarakis I., Flores C., Tracey J., Gordon M. Y., Habib N. A., Stem cells as a treatment for chronic liver disease and diabetes. Handbook of experimental pharmacology 2007 180 243 262 2-s2.0-34547573360
34. Liao S., Xia J., Chen Z., Zhang S., Ahmad A., Miele L., Sarkar F. H., Wang Z., Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of notch-1 and NF- B signaling pathways. Journal of Cellular Biochemistry 2011 112 4 1055 1065 2-s2.0-79952554406 10.1002/jcb.23019
35. Ohashi Y., Tsuchiya Y., Koizumi K., Sakurai H., Saiki I., Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 2003 65 3 250 258 2-s2.0-0345600100 10.1159/000074478
36. Cui S.-X., Qu X.-J., Xie Y.-Y., Zhou L., Nakata M., Makuuchi M., Tang W., Curcumin inhibits telomerase activity in human cancer cell lines. International Journal of Molecular Medicine 2006 18 2 227 231 2-s2.0-33751384016
37. Jia L., Wang H., Qu S., Miao X., Zhang J., CD147 regulates vascular endothelial growth factor-a expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma. IUBMB Life 2008 60 1 57 63 2-s2.0-42949148282 10.1002/iub.11
38. Wang Z., Zhang Y., Li Y., Banerjee S., Liao J., Sarkar F. H., Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics 2006 5 3 483 493 2-s2.0-33645473185 10.1158/1535-7163.MCT-05-0299
39. Cantarini M. C., De La Monte S. M., Pang M., Tong M., D'Errico A., Trevisani F., Wands J. R., Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and Notch signaling mechanisms. Hepatology 2006 44 2 446 457 2-s2.0-33747072601 10.1002/hep.21272
40. Gao J., Song Z., Chen Y., Xia L., Wang J., Fan R., Du R., Zhang F., Hong L., Song J., Zou X., Xu H., Zheng G., Liu J., Fan D., Deregulated expression of Notch receptors in human hepatocellular carcinoma. Digestive and Liver Disease 2008 40 2 114 121 2-s2.0-38049150094 10.1016/j.dld.2007.08.001
41. Qi R., An H., Yu Y., Zhang M., Liu S., Xu H., Guo Z., Cheng T., Cao X., Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Research 2003 63 23 8323 8329 2-s2.0-0346365362
42. Alao J. P., The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Molecular Cancer 2007 6 article 24 2-s2.0-34247149015 10.1186/1476-4598-6-24
43. Thorgeirsson S. S., Grisham J. W., Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006 43 1 2 8 2-s2.0-33644509480 10.1002/hep.21015
44. Jang Y.-Y., Collector M. I., Baylin S. B., Diehl A. M., Sharkis S. J., Hematopoietic stem cells convert into liver cells within days without fusion. Nature Cell Biology 2004 6 6 532 539 2-s2.0-2942749975 10.1038/ncb1132
45. Khakoo A. Y., Pati S., Anderson S. A., Reid W., Elshal M. F., Rovira I. I., Nguyen A. T., Malide D., Combs C. A., Hall G., Zhang J., Raffeld M., Rogers T. B., Stetler-Stevenson W., Frank J. A., Reitz M., Finkel T., Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. Journal of Experimental Medicine 2006 203 5 1235 1247 2-s2.0-33646690027 10.1084/jem.20051921
46. Aliotta J. M., Sanchez-Guijo F. M., Dooner G. J., Johnson K. W., Dooner M. S., Greer K. A., Greer D., Pimentel J., Kolankiewicz L. M., Puente N., Faradyan S., Ferland P., Bearer E. L., Passero M. A., Adedi M., Colvin G. A., Quesenberry P. J., Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 2007 25 9 2245 2256 2-s2.0-34748870750 10.1634/stemcells.2007-0128
47. Parekkadan B., Van Poll D., Suganuma K., Carter E. A., Berthiaume F., Tilles A. W., Yarmush M. L., Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007 2 9, article e941 2-s2.0-41549162430 10.1371/journal.pone.0000941
48. Qiao L., Xu Z., Zhao T., Zhao Z., Shi M., Zhao R. C., Ye L., Zhang X., Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Research 2008 18 4 500 507 2-s2.0-41849115243 10.1038/cr.2008.40
49. Yao J., Duan L., Fan M., Wu X., γ -secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells. Oral Diseases 2007 13 6 555 563 2-s2.0-35349020430 10.1111/j.1601-0825.2006.01334.x
50. Buhrmann C., Mobasheri A., Matis U., Shakibaei M., Curcumin mediated suppression of nuclear factor- B promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Research and Therapy 2010 12 4 article R127 2-s2.0-77954082316 10.1186/ar3065
51. Friedman R., Stem cells with curcumin reportedly help heal spinal cord. Neurology Today 2010 10 24 P20
52. Aggarwal B. B., Banerjee S., Bharadwaj U., Sung B., Shishodia S., Sethi G., Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochemical Pharmacology 2007 73 7 1024 1032 2-s2.0-33847133360 10.1016/j.bcp.2006.12.010
53. Abdel Aziz M. T., Fouad H. H., Roshdy N. K., Rashed L. A., Sabry D., Hassouna A. A., Taha F. M., Ibrahim W., Mahmoud M., Effect of human mesenchymal stem cells onhepatoma cell line. Stem Cell Studies 2011 1 article e12